Latest Insider Transactions at Natera, Inc. (NTRA)
This section provides a real-time view of insider transactions for Natera, Inc. (NTRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Natera, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Natera, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2026
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,867
-1.54%
|
$429,410
$230.43 P/Share
|
|
Jan 28
2026
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,413
-1.92%
|
$571,881
$237.55 P/Share
|
|
Jan 28
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,648
-1.68%
|
$864,576
$237.66 P/Share
|
|
Jan 28
2026
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
928
-0.53%
|
$219,936
$237.66 P/Share
|
|
Jan 28
2026
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
1,200
-0.84%
|
$284,400
$237.66 P/Share
|
|
Jan 28
2026
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-0.44%
|
$237,000
$237.66 P/Share
|
|
Jan 28
2026
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
191
-0.07%
|
$45,267
$237.66 P/Share
|
|
Jan 27
2026
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
784
-1.22%
|
$188,160
$240.53 P/Share
|
|
Jan 27
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
2,322
-1.06%
|
$557,280
$240.53 P/Share
|
|
Jan 27
2026
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
784
-0.44%
|
$188,160
$240.53 P/Share
|
|
Jan 27
2026
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
1,013
-0.7%
|
$243,120
$240.53 P/Share
|
|
Jan 27
2026
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
886
-0.39%
|
$212,640
$240.53 P/Share
|
|
Jan 27
2026
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
291
-0.11%
|
$69,840
$240.53 P/Share
|
|
Jan 23
2026
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
1,500
-0.96%
|
$364,500
$243.84 P/Share
|
|
Jan 21
2026
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
339
-0.19%
|
$79,665
$235.0 P/Share
|
|
Jan 21
2026
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
293
-0.2%
|
$68,855
$235.0 P/Share
|
|
Jan 21
2026
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
438
-0.19%
|
$102,930
$235.0 P/Share
|
|
Jan 21
2026
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,163
-0.4%
|
$740,142
$234.98 P/Share
|
|
Jan 21
2026
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
37,175
-18.46%
|
$8,847,650
$238.83 P/Share
|
|
Jan 21
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,590
-0.72%
|
$373,650
$235.0 P/Share
|
|
Jan 20
2026
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
17,806
-9.11%
|
$4,166,604
$234.74 P/Share
|
|
Jan 20
2026
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
23,205
-13.8%
|
$5,429,970
$234.74 P/Share
|
|
Jan 20
2026
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.37%
|
-
|
|
Jan 20
2026
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
19,234
-7.82%
|
$4,500,756
$234.74 P/Share
|
|
Jan 20
2026
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
191
+0.07%
|
-
|
|
Jan 20
2026
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,981
-1.1%
|
$697,554
$234.74 P/Share
|
|
Jan 20
2026
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+1.48%
|
-
|
|
Jan 20
2026
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
23,948
-19.36%
|
$5,603,832
$234.74 P/Share
|
|
Jan 20
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.51%
|
-
|
|
Jan 20
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
71,932
-24.87%
|
$16,832,088
$234.74 P/Share
|
|
Jan 14
2026
|
Jonathan Sheena |
BUY
Grant, award, or other acquisition
|
Direct |
7,450
+2.68%
|
-
|
|
Jan 14
2026
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,248
+13.16%
|
-
|
|
Jan 14
2026
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Grant, award, or other acquisition
|
Direct |
44,698
+21.0%
|
-
|
|
Jan 14
2026
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
44,698
+18.62%
|
-
|
|
Jan 14
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
152,718
+34.55%
|
-
|
|
Jan 14
2026
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
59,596
+32.51%
|
-
|
|
Jan 05
2026
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
39,615
+13.11%
|
$356,535
$9.59 P/Share
|
|
Jan 02
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,848
-1.38%
|
$881,192
$229.15 P/Share
|
|
Jan 02
2026
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
2,951
-1.17%
|
$672,828
$228.88 P/Share
|
|
Dec 19
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
1,500
-1.62%
|
$337,500
$225.58 P/Share
|
|
Dec 17
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.45%
|
$696,890
$227.42 P/Share
|
|
Dec 15
2025
|
Jonathan Sheena |
SELL
Bona fide gift
|
Direct |
1,060
-0.47%
|
-
|
|
Dec 15
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
115
-0.09%
|
-
|
|
Dec 12
2025
|
Herm Rosenman |
SELL
Open market or private sale
|
Direct |
48,419
-24.71%
|
$10,991,113
$227.89 P/Share
|
|
Dec 12
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Exercise of conversion of derivative security
|
Direct |
22,376
+8.32%
|
$201,384
$9.59 P/Share
|
|
Dec 12
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
4,692
-3.98%
|
$1,079,160
$230.76 P/Share
|
|
Dec 12
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
180
-0.17%
|
-
|
|
Dec 09
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
4,436
+1.92%
|
$39,924
$9.29 P/Share
|
|
Dec 05
2025
|
Rowan E Chapman |
SELL
Open market or private sale
|
Direct |
4,366
-22.7%
|
$1,060,938
$243.24 P/Share
|
|
Dec 05
2025
|
Rowan E Chapman |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+28.28%
|
$128,000
$32.15 P/Share
|